Adding stabilizing agents to the lipid bilayer or modifying the surface with ligands can help target specific tissues and minimize drug leakage. Manufacturing processes, such as high-pressure ...
The UniverXome subsidiary was established prior to Serina’s reverse merger with AgeX Therapeutics in March 2024 to own the legacy assets of the predecessor company.
SHANGHAI, China I January 20, 2025 I YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the ...